WHO webinar on 2018 DR-TB guidelines with TB stakeholders

World Health Organization
May 12, 2019, 11:40 p.m.

The World Health Organization (WHO) Task Force to support country transition towards new recommendations for the treatment of drug-resistant TB (DR-TB), created in August 2018, invites all interested TB stakeholders to participate in a webinar hosted by the WHO Global TB Program on 22 May 2019 from 14:00 to 15:30 (Central European Summer Time).

To register for the webinar, click here.
After your request has been approved, you'll receive instructions for joining the webinar.

The webinar will have two major objectives:

  1. To present an update on the progress achieved by countries and key stakeholders in supporting the transition towards the new WHO DR-TB recommendations.
  2. To address technical questions/concerns from TB stakeholders on the new WHO DR-TB recommendations. For the latter questions or concerns sould be submitted to LDR@who.int by EOB Friday 17 May 2019. As many questions/concerns as possible will be discussed within the time of the webinar.

Programme

14:00 – 14:05   

Opening remarks (Tereza Kasaeva, Director WHO Global TB Program)

14:05 – 14:10

Global Fund progress update on budgeting and reallocation of funds to support transition (Mohammed Yassin, Global Fund)

14:10 – 14:15

Global Drug Facility update on progress in drug resistant TB management issues (Brenda Waning, Director GDF)

14:15 – 14:25

Update on regional progress on behalf of rGLCs (Norbert Ndjeka, Chair rGLC AFRO and Fraser Wares, Chair rGLC SEARO)

14:25 – 14:30

Update on WHO global activities to support transition (Kefas Samson, WHO)

14:30 – 14:40

Questions on Task Force update

14:40 – 15:30

Discussion of technical questions on the Consolidated DR-TB treatment guidelines (Holger Schünemann and Gerry Davies, co-chairs of the Guideline Development Group WHO DR-TB 2018 guidelines update), including follow-up questions and some selected from the chat

15:30

Closing remarks (Tereza Kasaeva, Director WHO Global TB Program)